Walgreens to Stop Selling Abortion Pills by Mail in 20 States
  • last year
Walgreens to Stop , Selling Abortion Pills , by Mail in 20 States.
On March 2, one of America's largest
pharmacies said it would not distribute
abortion pills by mail in some states.
On March 2, one of America's largest
pharmacies said it would not distribute
abortion pills by mail in some states.
CBS reports that Walgreens confirmed the decision
to stop dispensing Mifepristone, stating that
the abortion drug will no longer be available in 20 states.
CBS reports that Walgreens confirmed the decision
to stop dispensing Mifepristone, stating that
the abortion drug will no longer be available in 20 states.
According to a letter dated February 1, Walgreens was warned by 20 attorneys general that the sale of abortion
drugs would violate both state and federal laws.
According to a letter dated February 1, Walgreens was warned by 20 attorneys general that the sale of abortion
drugs would violate both state and federal laws.
Last summer, following the overturning of Roe v. Wade,
Missouri was among several states to
implement strict prohibitions on abortion. .
Other states that Mifepristone will
no longer be available in include
Arkansas, Florida, Texas and West Virginia.
Other states that Mifepristone will
no longer be available in include
Arkansas, Florida, Texas and West Virginia.
We will only dispense in those
jurisdictions where it is legal
to do if we are certified, Walgreens, via statement.
CBS reports that over half
of all abortions in the U.S.
utilize Mifepristone.
For over 20 years, the FDA limited
the dispensing of the drug
due to safety concerns. .
For over 20 years, the FDA limited
the dispensing of the drug
due to safety concerns. .
Those restrictions were lifted amid
the COVID pandemic as a means of eliminating
the need for in-person appointments.
CBS reports that at least one lawsuit has been
filed against the FDA, claiming the agency
overstepped its authority in approving Mifepristone.
CBS reports that at least one lawsuit has been
filed against the FDA, claiming the agency
overstepped its authority in approving Mifepristone
Recommended